Product Pathways - Growth Factors/Cytokines
Human CD40 Ligand (hCD40L) #3583
|3583SF||50 µg (Carrier Free)||---||In Stock||---|
|3583SC||50 µg (With Carrier)||---||In Stock||---|
Already purchased this product? Write a Review.
Recombinant human CD40 Ligand (hCD40L) Met113-Leu261 (Accession #P29965) was produced in E. coli at Cell Signaling Technology.
Recombinant hCD40L has a Met on the amino terminus and has a calculated MW of 16,184. DTT-reduced and non-reduced protein migrate as 16 kDa polypeptides. The expected amino terminus MQKGD of recombinant hCD40L was verified by amino acid sequencing.
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hCD40L. All lots are greater than 98% pure.
The bioactivity of recombinant hCD40L was determined in a cell proliferation assay using human B cells. The ED50 of each lot is between 0.5-2 μg/ml.
The purity of recombinant hCD40L was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hCD40L and staining overnight with Coomassie Blue.
The proliferation of human B cells treated with increasing concentrations of hCD40L in the presence of 20 ng/ml human IL-4 (#8919) was assessed. After 96 hour treatment with hCD40L, cells were incubated with a tetrazolium salt and the OD450-OD650 was determined.
Western blot analysis of extracts from THP-1 cells, untreated or treated with hCD40L for 15 minutes, using Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb #4668 (upper) and SAPK/JNK (56G8) Rabbit mAb #9258 (lower).
Less than 0.01 ng endotoxin/1 μg hCD40L.
With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hCD40L. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.
CD40 Ligand (CD40L), a member of the TNF superfamily of ligands, is expressed as either a membrane-bound or soluble homotrimer (1). Both membrane-bound and soluble forms of CD40L have biological activity (1,2). CD40L is expressed primarily on activated T cells; however, mast cells, basophils, and NK cells may also express CD40L (1). CD40L functions as an important T cell co-stimulatory molecule and enhances T-dependent B cell responses (1,2). CD40L binds CD40, which is a receptor expressed on B cells, dendritic cells, and macrophages (1). Binding of CD40L to CD40 leads to the recruitment of TRAF proteins (TRAFs 2,3,5, and 6) resulting in the activation of the JNK and NF-κB pathways (1,2).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.